Biocon’s biologics facilities in Bengaluru received GMP compliance certificate from EMA

Read more

Univercells granted $14.3 mn to deliver affordable measles and rubella vaccines

Read more

Sun Pharma announces Late-Breaking Phase 2 data showing potential of ILUMYA (tildrakizumab-asmn)

Read more

DRL to sell neurology branded products to Upsher-Smith Laboratories

Read more

‘The Future of Supply Chain Management’ by OPPI

Read more

OPPI to host an event on ‘The Future of Supply Chain Management’

Read more

Wockhardt’s bioequivalence centre at Aurangabad receives zero observations from US FDA

Read more

Neelikon conferred with the ‘SME Elite 50’ award

Read more

Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology

Read more

Catalyst Pharma sues FDA over approval of cheaper rival drug

Read more